Zobrazeno 1 - 10
of 193
pro vyhledávání: ''
Publikováno v:
Value in Health, 24(7), 1038-1044. Elsevier Ltd.
Objectives This article aims to explore overlaps and differences between the emerging concept of value-based healthcare (VBHC) and the established field of cost-effectiveness analysis (CEA), as well as the feasibility of integrating them together. In
Publikováno v:
Value in Health. 24:1045-1058
Objectives A recent debate in health economics and outcomes research community identified option value as one of the elements warranting consideration in the assessment of medical technologies. To conduct a scoping review of contributions on option v
Publikováno v:
Value in Health. 24:839-845
Objectives To evaluate alternative methods to calculate and/or attribute economic surplus in the cost-effectiveness analysis of single or short-term therapies. Methods We performed a systematic literature review of articles describing alternative met
Publikováno v:
Value in Health. 24:388-396
Objectives Various strategies to address healthcare spending and medical costs continue to be debated and implemented in the United States. To date, these efforts have failed to adequately contain the growth of healthcare cost. An alternative strateg
Publikováno v:
Value in Health. 24:227-235
This study aims to estimate the national impact and cost-effectiveness of the 2018 American College of Physicians (ACP) guidance statements compared to the status quo.Survey data from the 2011-2016 National Health and Nutrition Examination were used
Autor:
Bohdan Nosyk, Benjamin Enns, Hawre Jalal, Xiao Zang, Emanuel Krebs, Ankur Pandya, Haoxuan Zhou
Publikováno v:
Value Health
Objectives The ambitious goals of the US Ending the HIV Epidemic initiative will require a targeted, context-specific public health response. Model-based economic evaluation provides useful guidance for decision making while characterizing decision u
Publikováno v:
Value in Health. 23:1543-1551
Objectives Reexamine cost-effectiveness of riluzole in the treatment of amyotrophic lateral sclerosis (ALS) in light of recent advances in disease staging and understanding of stage-specific drug effect. Methods ALS was staged according to the “fin
Autor:
Eva Wolf, Anja Neumann, Frederik Valbert, Stefan Preis, Knud Schewe, Nikola Hanhoff, Christian Hoffmann, Kathrin Pahmeier, Stephan Klauke, Jürgen Wasem
Publikováno v:
Value in Health. 23:1324-1331
Objectives The purpose of the prospective clinical and pharmacoeconomic outcomes study of different first-line antiretroviral treatment strategies (PROPHET) was to examine the healthcare costs of human immunodeficiency virus (HIV)–infected persons
Autor:
Andrew E. Grulich, Karl Johnson, John M. Kaldor, Fern Terris-Prestholt, Anna McNulty, Muhammad S Jamil, Martin Holt, Kirsty S Smith, Rebecca Guy, Adam Hynes, Benjamin R Bavinton, Mark Stoove, Richard De Abreu Lourenco, Deborah J. Street, Christopher K Fairley, Eric P F Chow, Jason J. Ong
Publikováno v:
Value in Health. 23:870-879
Objectives Human immunodeficiency virus self-testing (HIVST) is a promising approach to improve HIV testing coverage. We aimed to understand HIV testing preferences of men who have sex with men (MSM) to optimize HIVST implementation. Methods Discrete
Autor:
Nafsika Afentou, Philip Kinghorn
Publikováno v:
Value in Health. 23:515-526
Objectives Development of the ICEpop CAPability measure for Adults (ICECAP-A) was reported in 2012; use of certain capability measures was suggested in the context of social or long-term care soon afterward by decision-making organizations in the Uni